Promotion Plan for the Platform of Human Resource Development for Cancer (CancerHR Phase Two) had been launched in FY 2012. The newly selected five-year-project consists of 43 chairs in faculty of medicine: 9 chairs specialized in radiation treatment, 7 chairs specialized in chemotherapy, 10 chairs specialized in palliative care, and 17 other chairs. The above plans are expected to improve the platform of cancer education and research.
Human Resource Development Plan for Cancer (hereinafter referred to as CancerHR) was one of the educational projects established by Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) in fiscal year 2007. The program had been highly evaluated so far.
Increasing the number of death from cancer having reached 350,000 a year, and increasing the awareness of cancer patients and their family which is represented by numerous Cancer Patient Meetings eventually brought it to enforce the Cancer Control Act. Based on such a background, Can-cerHR had been launched. I would like to describe my expectation for"Promotion Plan for the Platform of Human Resource Development for Cancer" (CancerHR Phase Two) started in FY 2012 since I have an opportunity to oversee the entire project as a Chairman of the Committee of Promotion of Human Resource Development for Cancer (Table-1) .
CancerHR is a program for graduate student who specialized in clinical cancer, which has several features. First feature is that it aims to establish nationwide cancer treatment in cooperation with cancer medical treatment cooperation base hospitals. Second is that it aims to foster specialists, not only medical doctors but also nurses, pharmacists, and radiological medical physicist etc. In 4 years, the program achieved to foster more than 2,000 candidates (about 1,200 medical doctors) specialized in cancer. Third feature is that it placed great importance on radiation treatment, palliative care, and chemotherapy.
The research group of Ministry of Health, Labour and Welfare in Japan estimated that 2.25 million patients (diagnosed within 5 years) need cancer treatment in 2015. Although it seems like the actual number of cancer patients in need of treatment will go up to 4-5 million. Currently 15,000"General Clinical Oncologists"who have the latest and comprehensive knowledge are certified (as of April 2014) despite 50,000 specialists are necessary. Further, only 514 Certified Nurses Specialist in cancer nursing and 2,684 Certified Nurses in cancer nursing are certified as of January 2014. These numbers are far from sufficient.
Having been launched recently, CancerHR started to achieve fostering cancer specialists. At the same time it just started to collaborate between the specialists to make use of their professional skills, and universities and university hospitals had not been collaborated enough.
In view of the above, Promotion Plan for the Platform of Human Resource Development for Cancer (CancerHR Phase Two) had been launched in FY 2012 (Table-2 ). Based on the results and problems of Phase One, the following three results or effects are mainly picked up to make clear of target needs to proceed in Phase Two.
Construction of the cancer education research platform
Cancer education, research and medical treatment in Japan have been fallen far behind the international medical platform due to the separated operation in each of the internal organ specialties or medical specialties. This is because of insufficient cooperation between the internal organ specialties and medical specialties. Also the number of cross-disciplinary internal organ specialty chairs such as radiation treatment (separated from radiation diagnosis), chemotherapy (pharmacotherapy), and palliative care etc. are inadequate in number. Nevertheless, the newly selected five-year-project consists of 43 chairs: 9 chairs specialized in radiation treatment, 7 chairs specialized in chemotherapy, 10 chairs specialized in palliative care, and 17 other chairs. The above plans are expected to improve the platform of cancer education and research.
Promotion of cancer education reform
The project will accept 1,800 medical doctors specializing cancer treatment, and 1,200 medical personnel such as nurses and pharmacists in graduate school for 5 years. Other programs or education reforms are planned as follows:
1) In addition to educating cancer professionals in radiation treatment, chemotherapy, and palliative care, this project further set up a training course for surgical treatment, cancer treatment at home, pediatric cancer, gynecologic cancer, cancer rehabilitation, medical professionals, researcher and instructors who are involved in the latest and next-generation cancer research with the aim of extension of cancer professional education. 2) This project schedule to construct a new educational model to take advantage of characteristics of each university including a construction of e-Learning system, continuous interchange of personnel between local universities and universities in metropolitan area, programs applied to local networks having rooted in the area, programs principally aiming to team treatment, and education of researchers who are involved in the latest and next-generation research with the resource preserved in each university. 
Equal Accessibility to cancer treatment
Regardless of the residential area, patients should be able to access to cancer treatment of high quality based on a scientific knowledge (Equal Accessibility to cancer treatment). This project will foster cancer specialized professionals to work in those areas. The Following cases illustrate in detail.
1) This project is scheduled to open 83 courses to foster cancer professionals who will contribute the cancer treatment in local area, in which it will accept about 900 professionals in 5 years. 2) This project set up about 4 chairs specialized in local cancer medical cooperation such as local cancer treatment cooperation chair and local cancer treatment promotion chairs etc., in which it will promote to foster local oncologist, to construct local network, and to send oncologist to the local areas. 3) This project will open about 133 short-term learning courses (intensive courses) in graduate schools nationwide to accept about 3,000 professionals a year. This program enables the local medical professionals to learn the latest knowledge or treatment method of cancer preserved in universities.
Request from Committee of Promotion
Committee of Promotion requested the participating universities for the project as follows. 1) Conduct the plan accordingly as well as review to improve programs continuously to implement PDCA cycle with reference to an annual external evaluation conducted by external experts, comments from Committee of Promotion and social needs etc. 2) Return the result or effects to a society as much as possible and contribute the development of cancer treatment in Japan through educating excellent oncologists, and performing cutting-edge research and medical treatment for cancer. 3) Visualize the effort and effect as clear as possible to announce the public to recognize.
Committee of Promotion will continue to assess the progress of the project at interim evaluations and to support to enrich and develop the project.
Cancer control has been a critical issue for life and health of citizen in Japan thus Committee of Promotion requested the government to continue its financial support in which clearly stated on MEXT website.
As CancerHR Phase Two started,"National CancerHR Assembly"has been formally established by the universities selected for this program. The assembly is currently a private organization established with the aim to support programs at universities fostering cancer professionals involved in cancer treatment. Another objective of its establishment is to provide an occasion to exchange opinions of all universities belonged to the 15 main consortiums. Professor Nariaki Matsuura of Osaka University took the post as a Director. The Assembly held annual sectional meetings on palliative care in the first year (FY 2012), on radiation treatment in the second year (FY 2013), and will hold meeting on chemotherapy in the third year (FY 2014) . Those meetings are available to exchange opinions of each university and to improve the program. Also some programs are open to general public to expand a patient-oriented medical treatment. All the above activities are in progress every year.
Japan has one of the highest life expectancy rates in the world, together with high incidence of cancer and death caused by cancer. Longer life results in increasing cancer for which the current situation would be regretful. Yet improvement of cancer treatment will improve the Quality of Life of patients and further bring vitality to a family, an office, and a community. The achievement of our country will greatly contribute many other countries with aging population around the world. This could be the grounds to launch"CancerHR Phase Three" . Such successive CancerHR program will show a great value for cancer treatment and will foster personnel for contributing to cancer treatment worldwide in the future.
